Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Acorda Therapeutics announces issuance of additional U.S. Patent for AMPYRA® covering a range of dosage strengths
Value and Efficacy of Transcranial Direct Current Stimulation in the Cognitive Rehabilitation: A Critical Review Since 2000.
Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1.
Long-term daclizumab therapy in relapsing-remitting multiple sclerosis.
Receptos to deliver scientific presentations about RPC1063 at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Selective inhibition of CCR7- TEM cells activation by a novel peptide targeting Kv1.3 in a rat EAE model.
Title: Pharmacokinetics and Pharmacodynamics of Peginterferon Beta-1a in Patients with Relapsing-Remitting Multiple Sclerosis in the Randomised ADVANCE Study.
Glatiramer acetate treatment negatively regulates type I interferon signaling.
Biogen Idec and Abbott Announce Positive Top-Line Results from the First Registrational Trial for Daclizumab HYP in relapsing-Remitting Multiple Sclerosis
Receptos initiates clinical trials for S1P1 agonist program, aimed at multiple sclerosis
The correlation between symptomatic fatigue to definite measures of gait in people with multiple sclerosis.
Analysis of Onset Mechanisms of a Sphingosine 1-Phosphate Receptor Modulator Fingolomod-Induced Atrioventricular Conduction Block and QT-Interval Prolongation.
Fatal toxic epidermal necrolysis in a patient on teriflunomide treatment for relapsing multiple sclerosis.
Genzyme’s Lemtrada Recommended for Reimbursement on NHS by the National Institute for Health and Care Excellence (NICE)
Discontinuation of Disease-Modifying Treatment for Multiple Sclerosis
Subcutaneous IFN-β1a to treat relapsing-remitting multiple sclerosis.
Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis.
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
Ofatumumab Dose-finding in RRMS Patients
Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis.
Effects of prophylactic and therapeutic teriflunomide in transcranial magnetic stimulation-induced motor-evoked potentials in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.
Mitoxantrone for multiple sclerosis.
Neuropathology of white matter disease in Leber's hereditary optic neuropathy.
Cost-effectiveness analysis of interferon beta-1b as treatment for patients with clinically isolated syndrome suggestive of multiple sclerosis in Spain.

Pages